Myelodysplastic syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Meet the MDS-RCMD western medicine diagnosis and classification criteria; 2. Those who meet the TCM standard of deficiency of both spleen and kidney and block of poison and blood stasis; 3. The patient's age is 18 to 80 years old; 4. The patients gave informed consent, voluntarily participated in taking the medicine, and signed the informed consent.
Exclusion criteria
Exclusion criteria: 1. Combined with other serious blood system diseases, such as paroxysmal nocturnal hemoglobinuria, acute hematopoietic stagnation, myeloproliferative diseases, etc.; 2. Hereditary blood system diseases (including immediate family members within three generations); 3. Pregnant, lactating women, patients with reproductive needs or allergies; 4. Severe heart, liver and kidney dysfunction: serum creatinine greater than the upper limit of normal; alanine aminotransferase, aspartase, bilirubin greater than 2 times the normal value; NYHA grade >= grade II; or patients with neurological diseases; 5. Those who have taken other traditional Chinese medicines one month before treatment, or participated in other clinical studies, may have an impact on the efficacy observation indicators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| routine blood test;Bone marrow cytology;Liver and kidney function;electrocardiogram;Abdominal ultrasound; | — |
Countries
China
Contacts
Xiyuan Hospital, Chinese Academy of traditional Chinese Medicine